The FOXM1–ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells
Youxiang Hou(Central South University), Xiong Li(Central South University)
Cited by 128
Related Papers
PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cells
|Journal of Experimental & Clinical Cancer Research|2018|126